| Food City Pharmacy #606 | |
| 905 Snapps Ferry Rd, Greeneville, Tennessee 37745 | |
| (423) 638-8689 |
| Name | Food City Pharmacy #606 |
|---|---|
| Organization Name | K -va -t Food Stores Inc |
| Location | 905 Snapps Ferry Rd, Greeneville, Tennessee 37745 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (423) 638-8689 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Noting that the Supreme Court last week upheld the constitutionality of the Affordable Care Act, "mov[ing] the United States closer to the goal of health coverage for all," Pulitzer Prize-winning author Tina Rosenberg reports on health care coverage in Rwanda in this post in the New York Times' "Opinionator" blog.
There are few data on the effectiveness and mechanism underlying mild hypothermia in the treatment of central nervous system injuries. Therefore, there is a need to investigate the potentially beneficial effects of mild hypothermia on central nervous system injuries.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the SARS-CoV-2 spike protein. Both companies designed their vaccines to be delivered in two doses. However, given the limited supply of vaccines worldwide, a new modeling study has suggested that vaccinating more people with the first dose and delaying the second could be an alternate route to achieving population immunity that could reduce mortality rates.
› Verified 3 days ago
| NPI Number | 1144247503 |
| Organization Name | K VA T FOOD STORES INC |
| Doing Business As | FOOD CITY PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 905 Snapps Ferry Rd, Tusculum Blvd., Greeneville, TN 37745 |
| Phone Number | 423-638-8689 |
News Archive
Noting that the Supreme Court last week upheld the constitutionality of the Affordable Care Act, "mov[ing] the United States closer to the goal of health coverage for all," Pulitzer Prize-winning author Tina Rosenberg reports on health care coverage in Rwanda in this post in the New York Times' "Opinionator" blog.
There are few data on the effectiveness and mechanism underlying mild hypothermia in the treatment of central nervous system injuries. Therefore, there is a need to investigate the potentially beneficial effects of mild hypothermia on central nervous system injuries.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the SARS-CoV-2 spike protein. Both companies designed their vaccines to be delivered in two doses. However, given the limited supply of vaccines worldwide, a new modeling study has suggested that vaccinating more people with the first dose and delaying the second could be an alternate route to achieving population immunity that could reduce mortality rates.
› Verified 3 days ago
News Archive
Noting that the Supreme Court last week upheld the constitutionality of the Affordable Care Act, "mov[ing] the United States closer to the goal of health coverage for all," Pulitzer Prize-winning author Tina Rosenberg reports on health care coverage in Rwanda in this post in the New York Times' "Opinionator" blog.
There are few data on the effectiveness and mechanism underlying mild hypothermia in the treatment of central nervous system injuries. Therefore, there is a need to investigate the potentially beneficial effects of mild hypothermia on central nervous system injuries.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the SARS-CoV-2 spike protein. Both companies designed their vaccines to be delivered in two doses. However, given the limited supply of vaccines worldwide, a new modeling study has suggested that vaccinating more people with the first dose and delaying the second could be an alternate route to achieving population immunity that could reduce mortality rates.
› Verified 3 days ago
Atchley Drug Center Type: Community/Retail Pharmacy Location: 511 Asheville Hwy, Greeneville, Tennessee 37743 Phone: (423) 639-5155 | |
Bristol Orthotics & Prosthetics Inc Type: Prosthetic/Orthotic Supplier Location: 504 Justis Dr, Greeneville, Tennessee 37745 Phone: (423) 638-2670 | |
Central Drug Store Type: Pharmacy Location: 239 W Summer St, Greeneville, Tennessee 37743 Phone: (423) 638-4711 | |
East View Eye Care Pc Type: Medicare Supplier Location: 1000 Tusculum Blvd, Greeneville, Tennessee 37745 Phone: (423) 639-8128 | |
Greene County Drugstore Llc Type: Community/Retail Pharmacy Location: 906 Tusculum Blvd, Greeneville, Tennessee 37745 Phone: (423) 638-7101 |